Wealth Enhancement Advisory Services
JAZZ icon

Wealth Enhancement Advisory Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.1M Buy
18,651
+8,212
+79% +$1.8M 0.01% 1140
2026
Q1 		$1.95M Buy
10,439
+1,082
+12% +$189K ﹤0.01% 1402
2025
Q4 		$1.56M Buy
9,357
+3,182
+52% +$488K ﹤0.01% 1673
2025
Q3 		$848K Buy
6,175
+746
+14% +$89.5K ﹤0.01% 1972
2025
Q2 		$594K Buy
5,429
+1,095
+25% +$119K ﹤0.01% 2098
2025
Q1 		$538K Buy
4,334
+232
+6% +$30.3K ﹤0.01% 2009
2024
Q4 		$505K Buy
4,102
+743
+22% +$87.6K ﹤0.01% 1988
2024
Q3 		$374K Sell
3,359
-192
-5% -$21K ﹤0.01% 2031
2024
Q2 		$379K Buy
3,551
+768
+28% +$84.4K ﹤0.01% 1820
2024
Q1 		$335K Buy
2,783
+202
+8% +$24.7K ﹤0.01% 1844
2023
Q4 		$317K Sell
2,581
-410
-14% -$51.2K ﹤0.01% 1776
2023
Q3 		$387K Buy
+2,991
New +$399K ﹤0.01% 1586

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Wealth Enhancement Advisory Services's JAZZ Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Jazz Pharmaceuticals (JAZZ) stake by 79% in Q2 2026, buying an estimated $1.8M and bringing the position to 18,651 shares worth $4.1M. The position accounts for 0.01% of the portfolio, ranked #1140.

Wealth Enhancement Advisory Services first reported a position in JAZZ in Q3 2023 and has held it in 12 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Wealth Enhancement Advisory Services held 18,651 shares of Jazz Pharmaceuticals worth $4.1M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 8,212 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.8M.
  • Jazz Pharmaceuticals made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1140 holding.
  • Wealth Enhancement Advisory Services first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.